AI assistant
Sending…
RxSight, Inc. — Director's Dealing 2026
Jan 30, 2026
33077_dirs_2026-01-30_d58a76ba-86ef-43a9-bd5f-3c3085c5c084.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: RxSight, Inc. (RXST)
CIK: 0001111485
Period of Report: 2026-01-11
Reporting Person: Wilterding Mark (N/A)
More from RxSight, Inc.
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 25
Regulatory Filings
2026
Feb 25
Major Shareholding Notification
2026
Feb 3
Director's Dealing
2026
Jan 30